Sepsis Pathogenic Microorganism Detection Kit (Digital PCR)

In vitro diagnostic kit based on droplet digital PCR (dPCR) for the detection of pathogenic microorganisms associated with sepsis from DNA extracted from clinical samples. The kit allows identification and quantification of pathogens without requiring blood culture, covering 21 frequent agents in bloodstream infections.

Detailed Description

Principle of operation

The Sepsis Pathogenic Microorganism Detection Kit (Digital PCR) uses droplet digital PCR technology combined with TaqMan fluorescent probes to detect specific gene fragments of different pathogenic microorganisms. Each target is identified by one‑ or two‑color fluorescent probes and, by combining probes in different proportions, the system allows simultaneous detection of multiple pathogens in a single well.

During the procedure, microbial DNA extracted from the sample is randomly distributed into thousands of oil‑encapsulated droplets inside the digital PCR cartridge. After amplification, the fluorescent signals from each droplet are analyzed using statistical methods based on Poisson distribution, allowing precise detection of the microorganisms present.

The assay is organized into two main mixtures or panels, Sepsis Buffer 1 and Sepsis Buffer 2, which are processed separately for each sample and for the controls. Each reaction has a final volume of 20 µl and includes enzyme mix, specific buffer, nuclease‑free water, and sample or control DNA.

Clinical applications

The kit is designed for the detection of various pathogens involved in sepsis, a life‑threatening condition caused by microbial invasion of the bloodstream. The documentation indicates that bloodstream infection is a precursor to sepsis and can be caused by bacteria, viruses, and fungi. The product allows identification of types and loads of pathogenic microorganisms in blood without the need for blood culture. 21 frequent pathogenic agents in bloodstream infections, including Gram‑negative bacteria, Gram‑positive bacteria, and fungi.

Sepsis digital PCR kit workflow diagram

Detected microorganisms

The kit detects the following pathogens included in the two CE‑IVD panels:

Panel 1 Panel 2
  • Staphylococcus capitis
  • Acinetobacter baumannii
  • Candida tropicalis
  • Candida krusei
  • Staphylococcus epidermidis
  • Enterococcus faecium
  • Cryptococcus neoformans
  • Stenotrophomonas maltophilia
  • Klebsiella pneumoniae
  • Streptococcus pneumoniae
  • Serratia marcescens
  • Bacteroides fragilis
  • Escherichia coli
  • Candida parapsilosis
  • Candida glabrata
  • Enterobacter cloacae complex
  • Enterococcus faecalis
  • Haemophilus influenzae
  • Pseudomonas aeruginosa
  • Staphylococcus aureus
  • Candida albicans
Panel 2 also includes an internal control.

Benefits

Allows direct molecular detection of sepsis‑associated pathogens by digital PCR, without relying on blood culture growth. Provides rapid and accurate identification of microbial nucleic acids in whole blood, aimed at facilitating faster and targeted treatment. The RainSure workflow allows working with 3 ml of blood and obtaining results in an average of 3‑5 hours. Offers absolute quantification, high sensitivity, and rapid detection, according to the technological comparison included in the technical documentation. Allows detection of co‑infections and multiple pathogens in the same sample, according to the product technical description.

Key results or indicators

Interpretation of results is based on the count of positive droplets relative to the Limit of Blank (LoB) defined for each target. For all pathogens included in the panels, the indicated positive value is ≥3 positive droplets.

If the number of positive droplets for a target exceeds the LoB, the sample is reported as positive for that pathogen. If the number of positive droplets is below the LoB, the sample is reported as negative. If the number of positive droplets equals the LoB, it is recommended to repeat the assay with the maximum sample volume; if the repeat exceeds the LoB, the pathogen is reported as positive.

Technology used

The product is based on droplet digital PCR with multi‑channel fluorescent detection. The compatible system indicated in the IFU is the RainSure DropX‑2250 series digital PCR system, with five fluorescence channels: FAM, HEX, ROX, Cy5, and Cy5.5.

Intended user / audience

Qualified laboratory personnel trained in dPCR techniques.

Considerations or limitations

The kit is intended for in vitro diagnostic (IVD) use. Results may be affected by sample collection, handling, transport, and storage. Cross‑contamination can produce false positives. Inadequate collection, transport, or handling can generate false negatives. Variations in the analyzed target sequences can also cause false negatives. Use is restricted to the indicated sample types and analysis systems, including instrumental models, nucleic acid extraction reagents, and applicable methods.

Key Features

IVD kit for detection of sepsis‑associated pathogens.
Droplet digital PCR technology with TaqMan probes.
Detection of 21 frequent microorganisms in bloodstream infections.
Includes Gram‑positive bacteria, Gram‑negative bacteria, and fungi.
Allows detection without blood culture.
Compatible with RainSure DropX‑2250 system.
Multi‑channel analysis: FAM, HEX, ROX, Cy5, and Cy5.5.
Interpretation based on positive droplets and LoB ≥3.
Average time indicated in technical literature: 3‑5 hours.
Allows absolute quantification and detection of multiple pathogens in the same sample.

Presentation Details

Format and reference
Product: Sepsis Pathogenic Microorganism Detection Kit (Digital PCR) Reference: 3.02.03.0007 Presentation: 24 tests/kit Use: In vitro diagnostic (IVD)
Kit components
Sepsis Buffer 1: 1 vial of 210 µl. Contains dNTPs, MgCl₂, KCl, Tris‑HCl, and primers/probes for Panel 1 pathogens. Sepsis Buffer 2: 1 vial of 210 µl. Contains dNTPs, MgCl₂, KCl, Tris‑HCl, primers/probes for Panel 2 pathogens, and internal control primers/probes. Enzyme Mix: 1 vial of 60 µl, with Taq DNA polymerase. Sepsis Positive Control: 1 vial of 160 µl, with plasmids corresponding to the kit targets and internal control. Sepsis Negative Control: 1 vial of 160 µl, DNase/RNase‑free water.
Storage conditions
Store protected from light at a temperature below -15 °C. Shelf life: 12 months. Avoid more than 7 freeze/thaw cycles.
Sample types
The IFU indicates the following sample types:
Peripheral blood with EDTA anticoagulant. Sputum. Bronchoalveolar lavage. Cerebrospinal fluid. Pleural and abdominal fluid. Urine. Pus.
Required materials not included
RainSure Droplet Generation Oil for probes. RainSure Digital PCR Cartridge. RainSure Sealing Covers. Nuclease‑free water. Filter tips. Low‑binding, nuclease‑free centrifuge tubes. Pipette, centrifuge, and vortex.
×

Area:

CMI Quick Sepsis, Microbiology

Technology:

Brand:

Consult our experts

Google reCaptcha: Invalid site key.

Related products

SOPHiA DDM GEN2

Analytical platform for clinical genomics that enables the detection, annotation, and interpretation of genomic variants using artificial intelligence to support patient diagnosis and treatment. Detailed Description SOPHiA DDM™ Platform is an advanced solution for precision medicine workflows, with a renewed interface, web access, and new functionalities to accelerate genomic data analysis. It offers end‑to‑end workflows…
SOPHIA Genetics

PGT-SR (Preimplantation Genetic Testing for Chromosomal Structural Rearrangements)

PGT‑SR (Preimplantation Genetic Testing for Structural Chromosomal Rearrangements) is a solution aimed at the analysis of structural chromosomal rearrangements in embryos. According to the product literature, it is based on single‑cell whole‑genome amplification and NGS sequencing to detect embryos from patients with chromosomal abnormalities and select euploid embryos for transfer, with the aim of reducing…
Yikon Genomics
Next Generation Sequencing (NGS)

MaReCs (Mapping allele with resolved carrier state test)

MaReCs® (Allelic Mapping with Resolved Carrier Status) is a PGT‑SR technology that first identifies aneuploid or euploid embryos and then analyses translocation breakpoints and SNP linkage to differentiate carrier from non‑carrier euploid embryos. Detailed Description Principle of operation MaReCs® combines ChromSwift® technology with NGS sequencing to perform a CNV analysis and subsequently an SNP linkage…
Yikon Genomics
Next Generation Sequencing (NGS)

KaryoSeq (Integrated solution for PGT-M, PGT-SR and PGT-A)

KaryoSeq™ is a next‑generation sequencing (NGS)‑based solution for preimplantation genetic testing that enables PGT‑M, PGT‑SR and PGT‑A within a single workflow. It is designed for the analysis of DNA extracted from 3 to 10 trophectoderm cells of human embryos at the blastocyst stage. Detailed Description Principle of operation KaryoSeq™ is based on the MARSALA principle…
Yikon Genomics
Next Generation Sequencing (NGS)